FDA: Insulin among drugs transitioned to biological products
Insulin and other biologic drugs, such as human growth hormone, have now transitioned to being regulated as biological products, providing a new pathway for approval of biosimilars and interchangeable versions of these products ...
Mar 25, 2020
0
0